Fig. 2From: Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancerImpact of intermediate risk (positive) bronchial genomic classifier results on decision to take patients to an additional procedure after an inconclusive bronchoscopy. When physicians were presented cases with intermediate risk classifier results (n = 485), 65 % of the time they recommended a procedure, a 15 percentage point increase from when physicians were presented blinded cases associated with intermediate risk classifier results (50 % invasive procedure rate, n = 519, p < 0.001)Back to article page